Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy O'Brien

Showing results (301-310 of 340) with videos related to

Pageof 34
Sort By:
International Journal of Cancer|November 5, 2020
Targeting stromal cell Syndecan-2 reduces breast tumour growth, metastasis and limits immune evasionPaul G Loftus, Luke Watson, Laura M Deedigan, et al.
Cells|June 7, 2020
Administration of Human Non-Diabetic Mesenchymal Stromal Cells to a Murine Model of Diabetic Fracture Repair: A Pilot StudyLuke Watson, Xi Zhe Chen, Aideen E Ryan, et al.
American Journal of Medical Genetics. Part A|June 24, 2023
Heterozygous variants in TBCK cause a mild neurologic syndrome in humans and miceDivya Nair, Abdias Diaz-Rosado, Elisa Varella-Branco, et al.
Stem Cell Research & Therapy|March 5, 2024
Amelioration of diabetic nephropathy in mice by a single intravenous injection of human mesenchymal stromal cells at early and later disease stages is associated with restoration of autophagyJingjing He, Boxin Liu, Xiaofeng Du, et al.
Stem Cell Research & Therapy|November 17, 2016
Rapamycin regulates autophagy and cell adhesion in induced pluripotent stem cellsAreechun Sotthibundhu, Katya McDonagh, Alexander von Kriegsheim, et al.
Cytotherapy|April 11, 2020
Autologous bone marrow mesenchymal stromal cell therapy for "no-option" critical limb ischemia is limited by karyotype abnormalitiesSara Azhari Mohamed, Linda Howard, Veronica McInerney, et al.
Cytotherapy|October 17, 2012
Lentiviral vector delivery of short hairpin RNA to NG2 and neurotrophin-3 promotes locomotor recovery in injured rat spinal cordEleanor M Donnelly, Nicolas N Madigan, Gemma E Rooney, et al.
F1000Research|May 11, 2017
A double blinded, placebo-controlled pilot study to examine reduction of CD34 <sup>+</sup>/CD117 <sup>+</sup>/CD133 <sup>+</sup> lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphomaDaisuke Ito, Michael Childress, Nicola Mason, et al.
Stem Cell Research|February 12, 2021
Derivation of iPSC lines from two patients with autism spectrum disorder carrying NRXN1α deletion (NUIGi041-A, NUIG041-B; NUIGi045-A) and one sibling control (NUIGi042-A, NUIGi042-B)Yicheng Ding, Aisling O'Brien, Berta Marcó de la Cruz, et al.
Stem Cell Research|February 25, 2021
Derivation of four iPSC lines from a male ASD patient carrying a deletion in the middle coding region of NRXN1α gene (NUIGi039-A and NUIGi039-B) and a male sibling control (NUIGi040-A and NUIGi040-B)Yicheng Ding, Aisling O'Brien, Berta Marcó de la Cruz, et al.
Pageof 34

Showing results (301-310 of 340) with videos related to

Sort By:
Pageof 34
International Journal of Cancer|November 5, 2020
Targeting stromal cell Syndecan-2 reduces breast tumour growth, metastasis and limits immune evasionPaul G Loftus, Luke Watson, Laura M Deedigan, et al.
Cells|June 7, 2020
Administration of Human Non-Diabetic Mesenchymal Stromal Cells to a Murine Model of Diabetic Fracture Repair: A Pilot StudyLuke Watson, Xi Zhe Chen, Aideen E Ryan, et al.
American Journal of Medical Genetics. Part A|June 24, 2023
Heterozygous variants in TBCK cause a mild neurologic syndrome in humans and miceDivya Nair, Abdias Diaz-Rosado, Elisa Varella-Branco, et al.
Stem Cell Research & Therapy|March 5, 2024
Amelioration of diabetic nephropathy in mice by a single intravenous injection of human mesenchymal stromal cells at early and later disease stages is associated with restoration of autophagyJingjing He, Boxin Liu, Xiaofeng Du, et al.
Stem Cell Research & Therapy|November 17, 2016
Rapamycin regulates autophagy and cell adhesion in induced pluripotent stem cellsAreechun Sotthibundhu, Katya McDonagh, Alexander von Kriegsheim, et al.
Cytotherapy|April 11, 2020
Autologous bone marrow mesenchymal stromal cell therapy for "no-option" critical limb ischemia is limited by karyotype abnormalitiesSara Azhari Mohamed, Linda Howard, Veronica McInerney, et al.
Cytotherapy|October 17, 2012
Lentiviral vector delivery of short hairpin RNA to NG2 and neurotrophin-3 promotes locomotor recovery in injured rat spinal cordEleanor M Donnelly, Nicolas N Madigan, Gemma E Rooney, et al.
F1000Research|May 11, 2017
A double blinded, placebo-controlled pilot study to examine reduction of CD34 <sup>+</sup>/CD117 <sup>+</sup>/CD133 <sup>+</sup> lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphomaDaisuke Ito, Michael Childress, Nicola Mason, et al.
Stem Cell Research|February 12, 2021
Derivation of iPSC lines from two patients with autism spectrum disorder carrying NRXN1α deletion (NUIGi041-A, NUIG041-B; NUIGi045-A) and one sibling control (NUIGi042-A, NUIGi042-B)Yicheng Ding, Aisling O'Brien, Berta Marcó de la Cruz, et al.
Stem Cell Research|February 25, 2021
Derivation of four iPSC lines from a male ASD patient carrying a deletion in the middle coding region of NRXN1α gene (NUIGi039-A and NUIGi039-B) and a male sibling control (NUIGi040-A and NUIGi040-B)Yicheng Ding, Aisling O'Brien, Berta Marcó de la Cruz, et al.
Pageof 34